Zevalin-beam for Aggressive Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Avichai Shimoni, MD
Chaim Sheba Medical Center, Tel Hashomer, Israel
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georg-August Universität
Göttingen, Germany
- Chaim Sheba Medical Center
Tel Litwinsky, Israel
- Vu Medical Center
Amsterdam, Netherlands
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- City of Hope National Medical Center
Duarte, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Mayo Clinic
Rochester, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 28 Feb 2015
- Completion
- 28 Feb 2015
- Last update posted
- 31 Aug 2020
- Registered enrollment
- 60
- Registry id
- NCT00491491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.